Regulatory Activities: In April 2025, Sanofi and Regeneron Pharma received approval from the U.S. FDA for Dupixent (dupilumab) to treat adults and adolescents aged 12 years and older with chronic ...

The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for ...

When a super investor of India or like we call them, Warren Buffetts of India is interested in a stock/company, it becomes very apparent by their holdings in those companies. Ace investor Ashish ...

Investors' tariff jitters have returned to the forefront this week, as President Trump hinted at more fronts in his trade war ...

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

Even as tariff negotiations are ongoing between Canada and the United States, businesses aren't waiting for good news and are looking for alternative markets to the U.S.

Potential tariffs on imported medications could dramatically increase costs for American consumers and worsen existing drug ...

Trump continues to threaten new tariffs on Film and Pharma. Buyers pull back causing sellers to get anxious. The Saudi’s are mad as hell and announce June production increases. Bonds decline; yields ...

Waters raised its annual profit forecast on Tuesday, after reporting better-than-expected first quarter results due to higher demand for its medical instruments in Asia and the Americas.

S&P 500 E-Mini futures (ESM25) are trending down -0.82% this morning as the latest batch of corporate earnings reports ...

Stocks fell to start the week as investors hoping for news of trade deals instead had to grapple with another set of tariffs.

As BioNTech progresses with its goal to grow into a “fully integrated immunotherapy powerhouse,” the German biotech is e | ...